Related Experiment Video
Updated: Jul 20, 2025
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.7K
Anticoagulation for Stroke Prevention in Atrial Fibrillation
1The University of North Carolina at Chapel Hill School of Nursing, 7460 Carrington Hall, Chapel Hill, NC 27599, USA.
The Nursing Clinics of North America
|August 3, 2023
Summary
Oral anticoagulants prevent stroke in patients with atrial fibrillation, a major cause of disability. Nurses play a key role in educating patients on these vital treatments.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Atrial fibrillation is a significant cause of cardioembolic stroke in the U.S.
- These strokes lead to considerable mortality and long-term disability.
- Effective stroke prevention is crucial for managing patients with atrial fibrillation.
Purpose of the Study:
- To review current strategies for oral anticoagulant therapy in atrial fibrillation.
- To emphasize the importance of patient education in anticoagulation management.
- To highlight the essential role of nurses in optimizing stroke prevention.
Main Methods:
- Literature review of anticoagulation strategies for atrial fibrillation.
- Analysis of clinical guidelines and evidence-based practices.
- Discussion of the nurse's responsibilities in patient education and monitoring.
Main Results:
- Oral anticoagulants are proven safe and effective for stroke prevention in high-risk individuals.
- Anticoagulation therapy requires careful patient selection and ongoing management.
- Patient education is critical for adherence and minimizing bleeding risks.
Conclusions:
- Anticoagulation is a cornerstone of stroke prevention in atrial fibrillation.
- Nurses are integral to successful anticoagulation management through comprehensive patient education.
- Optimizing anticoagulation strategies can reduce the burden of stroke in the United States.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
01:30Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10